EXCAP delivered individualized daily step goals, resistance-band training, and activity diaries entirely at home, enabling scalable implementation within routine chemotherapy supportive-care pathways.

A 6-week structured exercise intervention during chemotherapy was associated with significantly less cancer-related cognitive impairment and mental fatigue compared with usual care. Benefits were ...

Chemotherapy-induced thrombocytopenia (CIT) is a common complication of chemotherapy that is associated with bleeding, reduced relative dose intensity, and potentially worse outcomes. No widely ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it alters gut bacteria and increases levels of a microbial molecule that travels to ...

Princess Kate is sharing a rare insight into her battle with cancer. The British royal, 43, opened up about her own experience with chemotherapy during a stop at Charing Cross Hospital in West London ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular Atrophy (SMA) to Hulus, a ...

A 49 year old woman was diagnosed with Philadelphia negative B-acute lymphoblastic leukemia (B-ALL) and subsequently started on induction chemotherapy with systemic cyclophosphamide, doxorubicin, ...

During and after cancer treatment with chemotherapy, up to 75 percent of people experience thinking and memory problems known as “chemo brain.” The cause of chemo rage can vary, says Dr. Cartagena, ...

Please provide your email address to receive an email when new articles are posted on . More than half of women treated for breast cancer experience distress from chemotherapy-induced hair loss.

Leptomeningeal metastasis (LM) is among the most severe complications in lung cancer patients, particularly for those without targetable gene mutations, who typically survive just 1–4 months. We ...